Large-scale genomics unveils the genetic architecture of psychiatric disorders

Nature Neuroscience

Volumn 17, Issue 6, 2014, Pages 782-790

  Gratten, Jacob ^a   Wray, Naomi R ^a   Keller, Matthew C ^b   Visscher, Peter M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXOME; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; REVIEW; STUDY DESIGN; SYNTHESIS; WHOLE EXOME SEQUENCING;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOMICS; HUMANS; MENTAL DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84901608878     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3708     Document Type: Review

References (96)

1. Lichtenstein, P., Carlstrom, E., Rastam, M., Gillberg, C. & Anckarsater, H. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am. J. Psychiatry 167, 1357-1363 (2010).
2. Lichtenstein, P. et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373, 234-239 (2009).
3. Ronald, A. & Hoekstra, R.A. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B, 255-274 (2011).
4. Sullivan, P.F., Kendler, K.S. & Neale, M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60, 1187-1192 (2003).
5. Wray, N.R. & Gottesman, I.I. Using summary data from the Danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front. Genet. 3, 118 (2012).
6. Eyre-Walker, A. Evolution in health and medicine Sackler colloquium: Genetic architecture of a complex trait and its implications for fitness and genome-wide association studies. Proc. Natl. Acad. Sci. USA 107 Suppl 1, 1752-1756 (2010).
7. Keller, M.C. & Miller, G. Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best? Behav. Brain Sci. 29, 385-452 (2006).
8. McClellan, J. & King, M.-C. Genetic heterogeneity in human disease. Cell 141, 210-217 (2010).
9. Hill, W.G., Goddard, M.E. & Visscher, P.M. Data and theory point to mainly additive genetic variance for complex traits. PLoS Genet. 4, e1000008 (2008).
10. Corvin, A., Craddock, N. & Sullivan, P.F. Genome-wide association studies: a primer. Psychol. Med. 40, 1063-1077 (2010).
11. Visscher, P.M., Brown, M.A., McCarthy, M.I. & Yang, J. Five years of GWAS discovery. Am. J. Hum. Genet. 90, 7-24 (2012).
12. McCarroll, S.A., Feng, G. & Hyman, S.E. Genome-scale neurogenetics: methodology and meaning. Nat. Neurosci. 17, 756-763 (2014).
13. Psychiatric Genomics Consortium Schizophrenia Working Group. Psychiatric Genomics Consortium quadruples schizophrenia GWAS sample-size to 35,000 cases and 47,000 controls. in XXIst World Congress of Psychiatric Genetics: Redefining Mental Illness Through Genetics (Boston, 2013).
14. European Alzheimer's Disease Initiative et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45, 1452-1458 (2013).
15. Charney, A.W. et al. Bipolar disorder GWAS of 13,741 cases and 19,762 controls identifies eight genome-wide significant hits and implicates genes targeted by FMRP protein. in XXIst World Congress of Psychiatric Genetics: Redefining Mental Illness Through Genetics (Boston, 2013).
16. Anney, R. et al. Meta-analysis of European ancestry individuals with autism spectrum disorder reveals strong association 3′ of the astrotactin 2 (ASTN2) gene locus on chromosome 9. in XXIst World Congress of Psychiatric Genetics: Redefining Mental Illness Through Genetics (Boston, 2013).
17. Neale, B.M. et al. Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 49, 906-920 (2010).
18. Wang, K. et al. A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. Mol. Psychiatry 16, 949-959 (2011).
19. Ripke, S. et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry 18, 497-511 (2013).
20. Davis, L.K. et al. Partitioning the heritability of tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet. 9, e1003864 (2013).
21. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium et al. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976 (2011).
22. Cross-Disorder Group of the Psychiatric Genomics Consortium et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379 (2013).
23. Pe'er, I., Yelensky, R., Altshuler, D. & Daly, M.J. Estimation of the multiple testing burden for genome-wide association studies of nearly all common variants. Genet. Epidemiol. 32, 381-385 (2008).
24. Sullivan, P.F. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron 68, 182-186 (2010).
25. Wray, N.R. et al. Genome-wide association study of major depressive disorder: new results, meta-analysis and lessons learned. Mol. Psychiatry 17, 36-48 (2012).
26. Purcell, S.M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009).
27. Shi, J. et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460, 753-757 (2009).
28. Ripke, S. et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150-1159 (2013).
29. Anderson-Schmidt, H. et al. Selected rapporteur summaries from the XX World Congress of Psychiatric Genetics, Hamburg, Germany, October 14-18, 2012. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 162B, 96-121 (2013).
30. Corder, E.H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923 (1993).
31. Klein, R.J. et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389 (2005).
32. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
33. Sullivan, P. Don't give up on GWAS. Mol. Psychiatry 17, 2-3 (2012).
34. Morris, A.P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981-990 (2012).
35. Plenge, R.M., Scolnick, E.M. & Altshuler, D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 12, 581-594 (2013).
36. Sanseau, P. et al. Use of genome-wide association studies for drug repositioning. Nat. Biotechnol. 30, 317-320 (2012).
37. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381 (2014).
38. Teslovich, T.M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010).
39. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
40. Lango Allen, H. et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467, 832-838 (2010).
41. Gilman, S.R. et al. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70, 898-907 (2011).
42. Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445-449 (2007).
43. Kirov, G. et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signaling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142-153 (2012).
44. Xu, B. et al. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 40, 880-885 (2008).
45. Williams, N.M. et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376, 1401-1408 (2010).
46. Malhotra, D. et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 72, 951-963 (2011).
47. Bergen, S.E. et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol. Psychiatry 17, 880-886 (2012).
48. Levinson, D.F. et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am. J. Psychiatry 168, 302-316 (2011)
49. Sanders, S.J. et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70, 863-885 (2011).
50. Vacic, V. et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 471, 499-503 (2011).
51. Williams, N.M. et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am. J. Psychiatry 169, 195-204 (2012).
52. Crespi, B., Stead, P. & Elliot, M. Evolution in health and medicine Sackler colloquium: comparative genomics of autism and schizophrenia. Proc. Natl. Acad. Sci. USA 107 Suppl 1, 1736-1741 (2010).
53. Levy, D. et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70, 886-897 (2011).
54. Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-99 (2012).
55. Neale, B.M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242-245 (2012).
56. O'Roak, B.J. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-50 (2012).
57. Sanders, S.J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237-241 (2012).
58. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014).
59. Purcell, S. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185-190 (2014).
60. Xu, B. et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet. 44, 1365-1369 (2012).
61. Hoischen, A., Krumm, N. & Eichler, E.E. Prioritization of neurodevelopmental disease genes by discovery of new mutations. Nat. Neurosci. 17, 764-772 (2014).
62. de Ligt, J. et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367, 1921-1929 (2012).
63. Kong, A. et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488, 471-475 (2012).
64. Michaelson, J.J. et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 151, 1431-1442 (2012).
65. McGrath, J.J. et al. A comprehensive assessment of parental age and psychiatric disorders. JAMA Psychiatry 71, 301-309 (2014).
66. Petersen, L., Mortensen, P.B. & Pedersen, C.B. Paternal age at birth of first child and risk of schizophrenia. Am. J. Psychiatry 168, 82-88 (2011).
67. Perrin, M.C., Brown, A.S. & Malaspina, D. Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia. Schizophr. Bull. 33, 1270-1273 (2007).
68. Samocha, K.E., Robinson, E., Neale, B. & Daly, M. Statistical evaluation of de novo variation implicates a distinct etiologic subtype of autism. in XXIst World Congress of Psychiatric Genetics: Redefining Mental Illness Through Genetics (Boston, 2013).
69. Liu, L. et al. Analysis of rare, exonic variation amongst subjects with autism spectrum disorders and population controls. PLoS Genet. 9, e1003443 (2013).
70. Ionita-Laza, I. et al. Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism. Proc. Natl. Acad. Sci. USA 111, 343-348 (2014).
71. Lee, S.H. et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984-994 (2013).
72. Lee, S.H. et al. Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Hum. Mol. Genet. 22, 832-841 (2013).
73. Yang, J. et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42, 565-569 (2010).
74. Lee, S.H., Wray, N.R., Goddard, M.E. & Visscher, P.M. Estimating missing heritability for disease from genome-wide association studies. Am. J. Hum. Genet. 88, 294-305 (2011).
75. Yang, J. et al. Ubiquitous polygenicity of human complex traits: genome-wide analysis of 49 traits in Koreans. PLoS Genet. 9, e1003355 (2013).
76. Gratten, J., Visscher, P.M., Mowry, B.J. & Wray, N.R. Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease. Nat. Genet. 45, 234-238 (2013).
77. Visscher, P.M., Goddard, M.E., Derks, E.M. & Wray, N.R. Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses. Mol. Psychiatry 17, 474-485 (2012).
78. Kapur, S., Phillips, A.G. & Insel, T.R. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol. Psychiatry 17, 1174-1179 (2012).
79. Allardyce, J., Suppes, T. & Van Os, J. Dimensions and the psychosis phenotype. Int. J. Methods Psychiatr. Res. 16 Suppl 1, S34-S40 (2007).
80. Kendler, K.S. & Gardner, C.O. The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies. Psychol. Med. 27, 411-419 (1997).
81. Lee, S.H., Yang, J., Goddard, M.E., Visscher, P.M. & Wray, N.R. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics 28, 2540-2542 (2012).
82. Bromet, E.J. et al. Diagnostic shifts during the decade following first admission for psychosis. Am. J. Psychiatry 168, 1186-1194 (2011).
83. Laursen, T.M., Agerbo, E. & Pedersen, C.B. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index. J. Clin. Psychiatry 70, 1432-1438 (2009).
84. Wray, N.R., Lee, S.H. & Kendler, K.S. Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes. Eur. J. Hum. Genet. 20, 668-674 (2012).
85. Lynch, M. & Walsh, B. Genetics and Analysis of Quantitative Traits (Sinauer Associates, 1998).
86. Ji, J. et al. Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr. Bull. 39, 527-536 (2013).
87. Duncan, L.E. & Keller, M.C. A critical review of the first 10 years of candidate geneby-environment interaction research in psychiatry. Am. J. Psychiatry 168, 1041-1049 (2011).
88. McGrath, J.J., Mortensen, P.B., Visscher, P.M. & Wray, N.R. Where GWAS and epidemiology meet: opportunities for the simultaneous study of genetic and environmental risk factors in schizophrenia. Schizophr. Bull. 39, 955-959 (2013).
89. Medland, S.E., Jahanshad, N., Neale, B.M. & Thompson, P.M. Whole-genome analyses of whole-brain data: working within an expanded search space. Nat. Neurosci. 17, 791-800 (2014).
90. WHO. The Global Burden of Disease: 2004 Update (WHO Press, 2008).
91. de Candia, T.R. et al. Additive genetic variation in schizophrenia risk is shared by populations of African and European descent. Am. J. Hum. Genet. 93, 463-470 (2013).
92. Yang, L. et al. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 162B, 419-430 (2013).
93. Sullivan, P.F. The genetics of schizophrenia. PLoS Med. 2, e212 (2005).
94. Yang, J., Visscher, P.M. & Wray, N.R. Sporadic cases are the norm for complex disease. Eur. J. Hum. Genet. 18, 1039-1043 (2010).
95. Turner, M.R. et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 12, 310-322 (2013).
96. Sebat, J., Levy, D.L. & McCarthy, S.E. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 25, 528-535 (2009).